James T. Borello RIA’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56.3K Sell
1,484
-150
-9% -$6.92K 0.01% 225
2026
Q2
$78.3K Buy
1,634
+52
+3% +$2.23K 0.02% 192
2026
Q1
$58.1K Buy
1,582
+1,559
+6,778% +$73.9K 0.01% 205
2025
Q4
$1.17K Buy
+23
New +$1.18K ﹤0.01% 858

Other funds holding NVO

James T. Borello RIA's NVO Position: Q3 2026 in Review

James T. Borello RIA reduced its Novo Nordisk (NVO) stake by 9.2% in Q3 2026, selling an estimated $6.92K and leaving 1,484 shares worth $56.3K. The position accounts for 0.01% of the portfolio, ranked #225.

James T. Borello RIA first reported a position in NVO in Q4 2025 and has held it in 4 quarters since. The position peaked at $78.3K in Q2 2026. 318 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • James T. Borello RIA held 1,484 shares of Novo Nordisk worth $56.3K as of Q3 2026.
  • James T. Borello RIA sold 150 Novo Nordisk shares in Q3 2026, an estimated $6.92K.
  • Novo Nordisk made up 0.01% of James T. Borello RIA's portfolio in Q3 2026, its #225 holding.
  • James T. Borello RIA first reported a position in Novo Nordisk in Q4 2025 and has held it in 4 quarters since.
  • James T. Borello RIA's Novo Nordisk position peaked at $78.3K in Q2 2026.
  • 318 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on James T. Borello RIA's 13F filing for Q3 2026, filed 16 Oct 2026.